CD274 and non-small cell lung carcinoma: In fact, tumor expression of PD-L1 functions as a marker for predicting response to therapy in certain types of cancer, as exemplified by NSCLC.3 It is therefore critical to delineate the molecular mechanism of PD-L1 expression to select the agent(s) likely to exhibit therapeutic activity for individual patient tumors.